Skip to main content

Want a detailed portfolio tracker?

ProQR Therapeutics N.V (PRQR) P/E (2014 - 2026)

ProQR Therapeutics N.V (PRQR) P/E from Sep 18, 2014 to Jul 21, 2026. The TTM ProQR Therapeutics N.V (PRQR) P/E is -3.73. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of ProQR Therapeutics N.V (PRQR)

YearP/EChange
2026-3.73-15.35%
2025-4.41-39.30%
2024-7.27+77.79%
2023-4.09+13.85%
2022-3.59-49.84%
2021-7.16+83.47%
2020-3.90-39.99%
2019-6.50-47.79%
2018-12.45+633.61%
2017-1.70-39.62%
2016-2.81-68.01%
2015-8.79-75.15%
2014-35.36N/A

Comparison ProQR Therapeutics N.V (PRQR) P/E with competitors

ProQR Therapeutics N.V (PRQR) P/E is -3.73.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.12%
ENLVEnlivex Ltd0.07-102.00%
FGENFibroGen Inc0.24-106.43%
CHRSCoherus Biosciences Inc0.85-122.73%
FBIOFortress Biotech Inc0.95-125.42%
ORMPOramed Pharmaceuticals Inc1.50-140.26%
AGENAgenus Inc3.01-180.61%
INVAInnoviva Inc3.15-184.48%
VXRTVaxart Inc3.55-195.07%
CRMDCorMedix Inc3.63-197.18%
CVACCureVac N.V.4.45-219.07%
GLPGGalapagos NV4.86-230.14%
SRPTSarepta Therapeutics Inc4.88-230.76%
ABEOAbeona Therapeutics Inc5.39-244.30%
ABUSArbutus Biopharma Corp5.60-249.87%
ZVRAZevra Therapeutics Inc5.89-257.68%
SPROSpero Therapeutics Inc6.23-266.82%
CGENCompugen Ltd6.31-269.11%
RIGLRigel Pharmaceuticals6.87-284.06%
SLXNSilexion Therapeutics Corp7.30-295.41%
OMEROmeros Corporation9.26-347.98%
AUPHAurinia Pharmaceuticals Inc9.58-356.72%
PLXProtalix BioTherapeutics Inc10.89-391.70%
ACADAcadia Pharmaceuticals Inc11.73-414.13%
TBPHTheravance Biopharma Inc12.26-428.42%
ADMAAdma Biologics Inc12.42-432.60%
HRMYHarmony Biosciences Holdings Inc13.82-470.15%
SABSSAB Biotherapeutics Inc14.14-478.62%
NAGENiagen Bioscience Inc14.82-496.88%
INCYIncyte Corp15.82-523.78%
REGNRegeneron Pharmaceuticals Inc15.86-524.70%
PBYIPuma Biotechnology Inc17.32-563.77%
CPRXCatalyst Pharmaceuticals Inc17.44-567.08%
EXELExelixis Inc17.54-569.73%
TGTXTG Therapeutics Inc18.97-607.98%
MDXGMimedx Group Inc20.55-650.47%
XOMAXOMA Royalty Corp22.87-712.68%
ARGXArgen X SE24.30-750.80%
CTMXCytomX Therapeutics Inc24.82-764.81%
XOMAOXOMA Royalty Corp25.34-778.84%
HALOHalozyme Therapeutics Inc25.62-786.31%
XOMAPXOMA Royalty Corp25.67-787.55%
VRTXVertex Pharmaceuticals Inc27.99-849.82%
RPRXRoyalty Pharma plc - Class A28.69-868.37%
SLNOSoleno Therapeutics Inc29.02-877.15%
ASNDAscendis Pharma A/S30.09-905.82%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1115.44%
APLSApellis Pharmaceuticals Inc39.02-1145.15%
BMRNBiomarin Pharmaceutical Inc42.21-1230.61%
KRYSKrystal Biotech Inc45.34-1314.49%
ONCBeiGene Ltd69.54-1962.58%
PHARPharming Group N.V.75.03-2109.50%
TECHBio-Techne Corp101.96-2830.87%
VCELVericel Corp109.92-3044.15%
ALNYAlnylam Pharmaceuticals Inc117.96-3259.60%
GMABGenmab140.29-3857.57%
TLXTelix Pharmaceuticals Ltd162.15-4443.13%
CORTCorcept Therapeutics Inc212.86-5801.21%